Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heuser

Showing results (161-170 of 280) with videos related to

Pageof 28
Sort By:
Bone Marrow Transplantation|May 21, 2024
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantationKristin Rathje, Nico Gagelmann, Rachel B Salit, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 17, 2016
[Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias]Ute Kossak-Roth, Susanne Saußele, Carlo Aul, et al.
Oncogene|June 2, 2018
Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic optionHauke Stamm, Felix Klingler, Eva-Maria Grossjohann, et al.
Genome Research|October 14, 2008
In-depth characterization of the microRNA transcriptome in a leukemia progression modelFlorian Kuchenbauer, Ryan D Morin, Bob Argiropoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemiaFrederik Damm, Tina Oberacker, Felicitas Thol, et al.
Blood|March 5, 2011
Integrative prognostic risk score in acute myeloid leukemia with normal karyotypeFrederik Damm, Michael Heuser, Michael Morgan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2015
Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic EffectsJasmin Wellbrock, Emily Latuske, Julian Köhler, et al.
Blood|March 20, 2023
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantationNico Gagelmann, Anita Badbaran, Rachel B Salit, et al.
Leukemia|August 16, 2023
Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemiaTheresa Eifert, Chen-Jen Hsu, Alicia L Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factorKatharina Wagner, Frederik Damm, Gudrun Göhring, et al.
Pageof 28

Showing results (161-170 of 280) with videos related to

Sort By:
Pageof 28
Bone Marrow Transplantation|May 21, 2024
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantationKristin Rathje, Nico Gagelmann, Rachel B Salit, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 17, 2016
[Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias]Ute Kossak-Roth, Susanne Saußele, Carlo Aul, et al.
Oncogene|June 2, 2018
Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic optionHauke Stamm, Felix Klingler, Eva-Maria Grossjohann, et al.
Genome Research|October 14, 2008
In-depth characterization of the microRNA transcriptome in a leukemia progression modelFlorian Kuchenbauer, Ryan D Morin, Bob Argiropoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemiaFrederik Damm, Tina Oberacker, Felicitas Thol, et al.
Blood|March 5, 2011
Integrative prognostic risk score in acute myeloid leukemia with normal karyotypeFrederik Damm, Michael Heuser, Michael Morgan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2015
Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic EffectsJasmin Wellbrock, Emily Latuske, Julian Köhler, et al.
Blood|March 20, 2023
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantationNico Gagelmann, Anita Badbaran, Rachel B Salit, et al.
Leukemia|August 16, 2023
Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemiaTheresa Eifert, Chen-Jen Hsu, Alicia L Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factorKatharina Wagner, Frederik Damm, Gudrun Göhring, et al.
Pageof 28